PUBLISHER: The Business Research Company | PRODUCT CODE: 1939264
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939264
An artificial intelligence (AI) enhanced sleep apnea oral device is an intelligent, custom-fitted appliance developed to maintain an open airway during sleep by gently adjusting the position of the jaw or tongue. It employs artificial intelligence to monitor breathing patterns in real time, adapting based on the user's sleep data to enhance both comfort and effectiveness.
The primary product categories of artificial intelligence (AI) enhanced sleep apnea oral devices include mandibular advancement devices, tongue-retaining devices, hybrid devices, and others. A mandibular advancement device works by gently moving the lower jaw forward during sleep to widen the upper airway and prevent its collapse. These devices feature advanced technologies such as artificial intelligence (AI) based monitoring, smart sensors, and data analytics and are distributed through both online and offline channels. They are used for applications such as obstructive sleep apnea, central sleep apnea, and complex sleep apnea syndrome, catering to end users including hospitals, sleep clinics, home care environments, and others.
Tariffs are impacting the AI-enhanced sleep apnea oral device market by increasing costs of embedded sensors, microprocessors, and smart materials, particularly impacting manufacturers in North America and Europe. Mandibular advancement and hybrid device segments face pricing pressures due to reliance on imported electronic components. However, tariffs are driving innovation in localized production and simplified device architectures, supporting long-term market expansion.
The artificial intelligence (AI)-enhanced sleep apnea oral device market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-enhanced sleep apnea oral device market statistics, including artificial intelligence (AI)-enhanced sleep apnea oral device industry global market size, regional shares, competitors with a artificial intelligence (AI)-enhanced sleep apnea oral device market share, detailed artificial intelligence (AI)-enhanced sleep apnea oral device market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced sleep apnea oral device industry. This artificial intelligence (AI)-enhanced sleep apnea oral device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial intelligence (ai)-enhanced sleep apnea oral device market size has grown rapidly in recent years. It will grow from $1.33 billion in 2025 to $1.51 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to rising sleep apnea prevalence, limitations of CPAP therapy, growth in dental sleep medicine, early adoption of smart oral devices, increasing awareness of sleep health.
The artificial intelligence (ai)-enhanced sleep apnea oral device market size is expected to see rapid growth in the next few years. It will grow to $2.5 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to AI-enabled adaptive sleep therapy, growth in home-based sleep treatment, integration with sleep monitoring apps, demand for non-invasive solutions, personalized sleep analytics. Major trends in the forecast period include personalized oral appliance therapy, real-time sleep pattern optimization, ai-based comfort adjustment, home sleep disorder management, data-driven therapy compliance.
The increasing healthcare expenditure is expected to drive the growth of the artificial intelligence (AI) enhanced sleep apnea oral device market in the coming years. Healthcare expenditure refers to the total spending on medical services, treatments, and health-related products aimed at maintaining or improving population health. This expenditure is rising due to the growing prevalence of chronic diseases that require long-term management and ongoing medical care, leading to higher overall healthcare costs. Increased healthcare spending supports the adoption of artificial intelligence (AI) enhanced sleep apnea oral devices by enabling greater investment in advanced diagnostic and treatment technologies that enhance patient outcomes and lower long-term healthcare expenses. For example, in April 2025, the Office for National Statistics, a government agency in the United Kingdom, reported that government-funded healthcare accounted for the majority of total health spending in the country, reaching $346 billion (£258 billion) in 2024, a 2.5 percent real-terms increase compared to 2023. Therefore, the rising healthcare expenditure is contributing to the growth of the artificial intelligence (AI) enhanced sleep apnea oral device market.
Leading companies in the artificial intelligence (AI) enhanced sleep apnea oral device market are focusing on developing innovative designs, such as bioengineered 3D anatomical designs, to enhance device precision, personalization, and treatment effectiveness. Bioengineered 3D anatomical design is an advanced approach that uses artificial intelligence and robotic manufacturing to produce customized oral devices tailored to each patient's dental and airway structure, improving comfort, jaw alignment, and breathing efficiency. For instance, in June 2025, ProSomnus Inc., a medical device company based in the United States, introduced EVO Guided, a precision-engineered, custom oral device for the treatment of obstructive sleep apnea (OSA). The device offers superior comfort through a lingual-less design, enhancing patient compliance and reducing side effects compared to traditional appliances. Its advanced anatomical fit and patented post mechanism effectively expand airway regions, making it a highly effective, FDA-cleared alternative to CPAP therapy.
In September 2024, US ENT Partners, a group purchasing organization based in the United States, partnered with ProSomnus Inc. to improve access to precision oral appliance therapy for patients with obstructive sleep apnea (OSA). This collaboration aims to empower ENT and dental sleep medicine professionals with advanced AI-enhanced oral appliance therapy solutions that improve patient outcomes, facilitate access to effective OSA treatment, and support practice growth through clinical and reimbursement assistance. ProSomnus Inc. is a United States-based medical device company that manufactures artificial intelligence (AI) enhanced sleep apnea oral devices.
Major companies operating in the artificial intelligence (ai)-enhanced sleep apnea oral device market are SomnoMed Limited, ProSomnus Sleep Technologies, Panthera Dental, Glidewell Laboratories Inc., DynaFlex Inc., Vivos Therapeutics Inc., OpenAirway Dental Solutions Ltd., Airway Management Inc., Apnea Sciences Corporation, OravanOSA, Myerson LLC, Braebon Medical Corporation, Klearway Inc., TOMED GmbH, Apex Dental Sleep Lab Inc., Dream Systems LLC, OrthoApnea S.L., Dentulu Inc., Airway Labs, Zyppah Inc.
North America was the largest region in the artificial intelligence (AI)-enhanced sleep apnea oral device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-enhanced sleep apnea oral device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial intelligence (AI)-enhanced sleep apnea oral device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The artificial intelligence (AI)-enhanced sleep apnea oral device market consists of revenues earned by entities by providing services such as custom fitting, remote monitoring, sleep data analysis, teleconsultation, maintenance and repair, and software updates. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced sleep apnea oral device market also includes sales of oral appliances, sensor modules, adaptive control systems, and digital sleep trackers. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Intelligence (AI)-Enhanced Sleep Apnea Oral Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses artificial intelligence (ai)-enhanced sleep apnea oral device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for artificial intelligence (ai)-enhanced sleep apnea oral device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-enhanced sleep apnea oral device market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.